”We have to create respect”
The Danish gene analysis company, Exiqon, is still struggling to secure the same level of growth rates in the US as they see in Europe. But following a difficult period things are looking up. The top line should be boosted, says CEO Lars Kongsbak, and new products play a crucial role in this regard.
by Benjamin Werner Christensen
It is often said that it can be extremely difficult to secure growth outside of ones home country, but the listed, Danish company Exiqon is living prove that it can be done. The company, which is still in the red but close to breaking even, generates between 97 and 98 % of its turnover outside of Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75)
